Current Report Filing (8-k)
March 10 2023 - 4:17PM
Edgar (US Regulatory)
0001415684
false
0001415684
2023-03-09
2023-03-09
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (date of earliest event reported): March 9, 2023
MusclePharm
Corporation
(Exact
Name of Registrant as Specified in Charter)
Nevada
(State
of Incorporation)
000-53166 |
|
77-0664193 |
(Commission
File Number) |
|
(I.R.S.
Employer Identification No.) |
7380
S. Eastern Ave., Ste. 124-287 Las
Vegas, NV |
|
89123 |
(Address
of Principal Executive Offices) |
|
(Zip
Code) |
(800)
859-3010
(Registrant’s
Telephone Number, Including Area Code)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425). |
|
|
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12). |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)). |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)). |
Securities
registered pursuant to Section 12(b) of the Act
Title
of Each Class |
|
Trading
Symbol |
|
Name
of Each Exchange on Which Registered |
N/A |
|
N/A |
|
N/A |
Securities
registered pursuant to Section 12(g) of the Act: Common Stock, par value $0.001 per share
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.
Appointment
of Nicholas Rubin to the Board of Directors
On
January 19, 2023, MusclePharm Corporation (the “Company”) appointed Nicholas Rubin to serve as a member of the board of directors.
There are no family relationships between Mr. Rubin and any other director or officer of the Company. There are no transactions in which
Mr. Rubin has an interest requiring disclosure under Item 404(a) of Regulation S-K. Set forth below is the biographical information of
Mr. Rubin.
Nicholas
Rubin co-founded Force 10 Partners and has more than 25 years of combined leadership experience in large enterprise, capital markets,
financial planning, commercial real estate, and corporate finance. Nicholas has experience building comprehensive strategic plans for
entities by incorporating financial analysis, restructuring expertise, investment banking capabilities, operational turnaround management
and business intelligence to drive and facilitate sustainable growth.
Nicholas
has served in roles as a Chief Restructuring Officer, Financial Advisor, Fiduciary, Investment Banker, Expert Witness, and a host of
other executive leadership roles.
Nicholas
earned a Bachelor of Commerce degree in financial and management accounting, auditing, business management, marketing, and finance from
a leading international business school in South Africa.
On
February 13, 2023, the Company appointed Eric Hillman to serve as the organization’s Chief Executive Officer and as a member of
the board of directors. There are no family relationships between Mr. Hillman and any other director or officer of the Company. There
are no transactions in which Mr. Hillman has an interest requiring disclosure under Item 404(a) of Regulation S-K. Set forth below is
the biographical information of Mr. Hillman.
Eric
Hillman is the Co-Founder of Europa Sports, Headquarters in Charlotte, NC, an industry-leading distributor of nutritional and sports
supplements, sports drinks, and accessories with more than 6,000 products representing 300 plus brands. Eric partnered in his first Fitness
Center in 1985 in Winston-Salem, NC, and later opened Powerhouse Gym Winston-Salem. He is the current owner of Linny Mac’s Powerhouse
Gym. Eric serves as a National Physique Committee and IFBB Professional Judge. Eric was a director for the USA Rugby Trust, the philanthropic
arm of USA Rugby. Eric was on the Strength and Conditioning Department for Appalachian State University during 2015-2019 as the Head
Size Coach winning 4 consecutive bowl game appearances. He is a member of the ISSN, the
only non-profit academic society dedicated to promoting the science and application of evidence-based sports nutrition and supplementation.
Eric is also a Global Advisory member for The International Sports Hall of Fame, established to
honor the world’s greatest athlete legends in all sports.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
March
9, 2023 |
By: |
/s/
Eric Hillman |
|
|
Eric
Hillman |
|
|
Chief
Executive Officer |
Muscle Pharm (CE) (USOTC:MSLP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Muscle Pharm (CE) (USOTC:MSLP)
Historical Stock Chart
From Jul 2023 to Jul 2024